Patient Registry Privacy Notice
Join the Patient Registry
Over the past year, three people with paralysis have received
Neuralink implants. This blog post explores the different and exciting
ways each person is using Telepathy in their daily lives.
We are excited to announce that we have received approval from
Health Canada to launch the CAN-PRIME Study, our first
international trial!
PRIME Study Progress Update — Second Participant
Last month, the second participant in our PRIME Study received his
Neuralink implant (Link). With the Link, he has been improving his
ability to play video games and began learning how to use computer-
aided design (CAD) software to design 3D objects. In this blog post,
we provide an update on our second participant’s experience with the
Link.
PRIME Study Progress Update — User Experience
People with quadriplegia often find that their needs to engage
seamlessly with the digital world go unmet, leading to decreased
independence, isolation, and financial challenges. Our goal is to
provide a high-performance interface that will enhance the control of
digital devices for people with quadriplegia, unlocking their personal
and professional potential.
PRIME Study Progress Update
In January, we conducted the first human implantation of our brain-
computer interface (BCI). We were able to detect the participant’s
neural signals shortly after the implantation surgery, and since then,
he has used our end-to-end BCI system for various applications, like
playing online chess and Sid Meier's Civilization VI*.
This marks a significant milestone towards making BCI technology
available to potentially restore autonomy to millions of people with
unmet medical needs. We’ve prepared this blog post to share a high-
level snapshot of where we are as a company: the mission that guides
us, the technology we have built, the study we are currently
conducting, and the work we have yet to do.
Neuralink’s Patient Registry Opens to Canada
Our Patient Registry is now accepting applications from Canadian
residents!
This international expansion allows us to assess preliminary eligibility
of participants for future Neuralink clinical trials in Canada.
Understanding Preclinical Research at Neuralink
Become acquainted with the Preclinical Team, which is responsible
for the design, conduct, documentation, analysis, and reporting of
preclinical studies. It is their responsibility to provide a means for
ensuring the implantation of Neuralink devices into animals, and
ultimately people, is safe, effective, and robust.
Neuralink’s First-in-Human Clinical Trial is Open for
Recruitment
We are happy to announce that we’ve received approval from the
reviewing independent institutional review board and our first
hospital site to begin recruitment for our first-in-human clinical trial.
The Role of the Institutional Animal Care and Use Committee
Our 3 R’s blog series continues, this time highlighting the importance
of the Institutional Animal Care and Use Committee (IACUC) and
its role in promoting Refinement, Reduction, and Replacement at a
research facility. All animal research must be conducted in an ethical
and humane manner. An institution's IACUC provides oversight that
is critical in achieving this requirement. In this blog article, we explore
the role and functions of Neuralink’s IACUC.
Environmental enrichment is used to maximize animal
, the top goals of Neuralink’s animal care program. In our second
blog on refinement, we highlight our methodology to ensure that we
are providing an enriching environment and experience to animals
within our care.
Announcing Neuralink's Patient Registry
Over the last few years, we have worked with patient advocacy groups
and a consumer advisory board consisting of individuals with spinal
cord injury and their caregivers to guide product development and
community engagement.
As an expansion of these efforts, we’ve launched a Patient Registry to
learn more about individuals who want to contribute to this initiative
and who may be interested in enrolling in future Neuralink clinical
trials, when they become available.
The first episode of our Refinement Series will look at how we
evaluate the well-being of an animal as it pertains to housing, food,
and water - the key elements of husbandry. We share examples of
how we identify gaps in our program and how we tackle those with the
help and support of our engineers and animal care teams.
At Neuralink, we are committed to championing the “3 Rs” of
research:
In this blog post, we describe the 3 Rs and introduce our upcoming
multi-part series highlighting the challenges we encounter in animal
medical research. We discuss how we think about solutions to these
problems using the framework of the 3 Rs. We hope you will take this
opportunity to learn alongside us as we dive into the complex world of
ensuring animal well-being in a research setting.
Neuralink's Commitment to Animal Welfare
Animals at Neuralink are respected and honored by our team.
Without proper context, information from medical records and study
data can be misleading. In this blog post, we want to provide an
accurate statement of Neuralink’s commitment to animal welfare.
Series C Funding Round Announcement
Neuralink Corp is pleased to announce our Series C funding round of
$205 million, led by Vy Capital, with participation from Google
Ventures, DFJ Growth, Valor Equity Partners, Craft Ventures,
Founders Fund, and Gigafund.
Neuralink is developing a fully-implanted, wireless, high-channel
count, brain-computer interface (BCI) with the goal of enabling
people with paralysis to directly use their neural activity to operate
computers and mobile devices with speed and ease.
